Follow
Matthew Baggott
Matthew Baggott
Tactogen Inc
Verified email at uchicago.edu - Homepage
Title
Cited by
Cited by
Year
Subjective and hormonal effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans
DS Harris, M Baggott, JH Mendelson, JE Mendelson, RT Jones
Psychopharmacology 162, 396-405, 2002
2862002
Test–retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention.
J Weafer, MJ Baggott, H de Wit
Experimental and clinical psychopharmacology 21 (6), 475, 2013
2662013
Cardiovascular effects of 3, 4-methylenedioxymethamphetamine: a double-blind, placebo-controlled trial
SJ Lester, M Baggott, S Welm, NB Schiller, RT Jones, E Foster, ...
Annals of Internal Medicine 133 (12), 969-973, 2000
1762000
Buprenorphine and naloxone interactions in opiate‐dependent volunteers
J Mendelson, RT Jones, I Fernandez, S Welm, AK Melby, MJ Baggott
Clinical Pharmacology & Therapeutics 60 (1), 105-114, 1996
1671996
Chemical analysis of ecstasy pills
M Baggott, B Heifets, RT Jones, J Mendelson, E Sferios, J Zehnder
Jama 284 (17), 2190-2190, 2000
1592000
Psychopharmacology of theobromine in healthy volunteers
MJ Baggott, E Childs, AB Hart, E de Bruin, AA Palmer, JE Wilkinson, ...
Psychopharmacology, 2013
1352013
Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers
J Mendelson, RT Jones, S Welm, M Baggott, I Fernandez, AK Melby, ...
Psychopharmacology 141, 37-46, 1999
1331999
A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction
GP Galloway, R Buscemi, JR Coyle, K Flower, JD Siegrist, LA Fiske, ...
Clinical Pharmacology & Therapeutics 89 (2), 276-282, 2011
1052011
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
AK Bershad, MA Miller, MJ Baggott, H de Wit
Journal of Psychopharmacology 30 (12), 1248-1258, 2016
1032016
Use patterns and self-reported effects of Salvia divinorum: an internet-based survey
MJ Baggott, E Erowid, GP Galloway, J Mendelson
Drug and alcohol dependence 111 (3), 250-256, 2010
1032010
Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire
MJ Baggott, JR Coyle, E Erowid, F Erowid, LC Robertson
Drug and alcohol dependence 114 (1), 61-67, 2011
922011
Mechanisms and genetics of antipsychotic‐associated weight gain
SL Balt, GP Galloway, MJ Baggott, Z Schwartz, J Mendelson
Clinical Pharmacology & Therapeutics 90 (1), 179-183, 2011
752011
MDMA effects consistent across laboratories
MG Kirkpatrick, MJ Baggott, JE Mendelson, GP Galloway, ME Liechti, ...
Psychopharmacology 231, 3899-3905, 2014
692014
Intimate insight: MDMA changes how people talk about significant others
MJ Baggott, MG Kirkpatrick, G Bedi, H de Wit
Journal of Psychopharmacology 29 (6), 669-677, 2015
572015
Caveat emptor: editors beware
FX Vollenweider, RT Jones, MJ Baggott
Neuropsychopharmacology 24 (4), 461-463, 2001
532001
Effects of 3, 4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting
MJ Baggott, JR Coyle, JD Siegrist, KJ Garrison, GP Galloway, ...
Journal of psychopharmacology 30 (4), 378-387, 2016
522016
Preventing problems in ecstasy users: Reduce use to reduce harm
MJ Baggott
Journal of Psychoactive Drugs 34 (2), 145-162, 2002
522002
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
JE Mendelson, JR Coyle, JC Lopez, MJ Baggott, K Flower, ET Everhart, ...
Psychopharmacology 214, 933-939, 2011
472011
Psychedelics and creativity: a review of the quantitative literature
MJ Baggott
PeerJ preprints, 2015
422015
Ketamine is associated with lower urinary tract signs and symptoms
R Pal, S Balt, E Erowid, F Erowid, MJ Baggott, J Mendelson, GP Galloway
Drug and alcohol dependence 132 (1-2), 189-194, 2013
392013
The system can't perform the operation now. Try again later.
Articles 1–20